Deutsche Bank AG London Post Stabilisation Notice - GlaxoSmithKline (0559Q)
16 Outubro 2019 - 5:43AM
UK Regulatory
TIDMAG99
RNS Number : 0559Q
Deutsche Bank AG London
16 October 2019
16-Oct-19
Not for distribution, directly or indirectly, in or into the
United States or any jurisdiction in
which such distribution would be unlawful.
GlaxoSmithKline Capital plc
Post-stabilisation Period Announcement
Further to the pre-stabilisation period announcement dated
16/09/2019(1) Deutsche Bank AG London (contact: DCM Syndication TA;
telephone: 0207 54 54153 hereby gives notice that no stabilisation
(within the meaning of Article 3.2(d) of the Market Abuse
Regulation (EU/596/2014) or the rules of the Financial Conduct
Authority)(2) was undertaken by the Stabilisation Manager(s)(3)
named below in relation to the offer of the following
securities.
The Securities:
Issuer: GlaxoSmithKline Capital plc
Guarantor (if any): GlaxoSmithKline plc
Aggregate nominal amount: EUR 2.5bn
Description: GlaxoSmithKline EUR 2y FRN and 2/4y FXD
Stabilisation Manager(s): BNPP, CS, DB, MS
Offer Price: 100.650 / 100.289 / 100.184
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
STACKADNFBDKOKD
(END) Dow Jones Newswires
October 16, 2019 04:43 ET (08:43 GMT)
Glaxosmsc 5.25% (LSE:AG99)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
Glaxosmsc 5.25% (LSE:AG99)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024